Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 7, 2025

Helios Fairfax Partners Announces Appointment of Michael Corcoran as Interim Chief Financial Officer
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced the appointment of Michael Corcoran as Interim …

PainReform Provides Year-End Business Update
TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the DeepSolar …

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
Auditor Licensing …

StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval
StarMab announces that US FDA has approved its Investigational New Drug (IND) application for SM2275, a novel dual-target nanobody-based anti-tumor therapy. BEIJING, CHINA, April 7, 2025 /EINPresswire.com/ -- Beijing StarMab BioMed Technology , Ltd. (“ …

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …

FRO – Filing of Annual Report
Frontline plc (the “Company”) announces the filing of its annual report for the year ended December 31, 2024. The annual report can be downloaded from the Company’s website www.frontlineplc.cy or from the link below. Additionally, shareholders can request …

Range Announces Conference Call to Discuss First Quarter 2025 Financial Results
FORT WORTH, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) announced today that its first quarter 2025 financial results news release will be issued Tuesday, April 22 after the close of trading on the New York Stock …

CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …

Innventure, Inc. to Announce Fourth Quarter and Full Year 2024 Results on April 11
ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a differentiated technology commercialization platform, today announced it will release its fourth quarter and full year 2024 financial results before market …

Sprout Social to Announce First Quarter 2025 Financial Results on May 8, 2025
CHICAGO, April 07, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the …

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …

Rumble & Rebel News sue MP Saks & others for conspiring to violate free speech rights
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Rumble Canada, (NASDAQ: RUM), the high-growth video platform and cloud services provider, has joined Rebel News Network and its founder, Ezra Levant, in suing the government of Canada, Member of Canadian …

AGM Group Holdings Inc. Receives Staff Determination Notice from Nasdaq and Plans to Appeal
Beijing, April 07, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee …

Astec Industries, Inc. Announces the Company’s First Quarter 2025 Conference Call on April 29, 2025, at 8:30 A.M. Eastern Time
CHATTANOOGA, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- You are invited by Astec Industries, Inc. (NASDAQ:ASTE) to participate in a conference call to review the company’s first quarter 2025 financial results. Astec Industries, Inc. will be releasing the …

Channel 4 Selects SplashBI for Financial and Self-Service Reporting
Channel 4 modernises reporting with hybrid analytics and pre-built dashboards integrated across key financial systems. LONDON, UNITED KINGDOM, April 7, 2025 /EINPresswire.com/ -- SplashBI, a leading provider of enterprise reporting and analytics …

Study of Pre- and Post-Rehabilitation of Cured-In-Place Pipe for Florida Utility Shows 63% Increase in Infiltration
Landmark 4-Year Study of CCTV …